Opioid receptors

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 12: Line 12:
The κ-opioid receptor is a <scene name='48/483884/K_or_general/1'>homodimer</scene>. The extracellular side is home to the proteins primary <scene name='48/483884/K_or_binding_general/2'>active site</scene>. These 2 units will span the length for the cell membrane to form the basis of the receptor molecule. <scene name='48/483884/K_or_dimmer_assembly/1'>The each subunit is attached to the other by the I, II and VIII α-helices</scene>, where helices I (in light blue) and helices VIII (in dark blue). This area will make up the basis for the intermembrane surface area. A distinguishing feature that separates the κ-opioid receptor from other receptors, is the large β-hairpin, <scene name='48/483884/K_or_beta_sheet/3'>ECL2</scene>, located near the main active site of the protein. It is believed that its function is to cap the active site of the receptor. Although in general, this protein is primarily composed of α-helices, not β-sheets (Compare <scene name='48/483884/K_or_beta_sheet/1'>β-sheet</scene> to <scene name='48/483884/K_or_alpha/1'>α-helices</scene>). This evidence reinforces the idea that this protein is a transmembrane protein rather than one found inside the cytosol. In general transmembrane protein are composed almost entirely of α-helices (or β-sheet arranged in special fashion called a β-barrel), in order to have maximum stability inside the membrane. Interesting feature of the κ-opioid receptor is the <scene name='48/483884/K_or_disulfide_bond/1'>disulfide bond </scene> formed by Cys131 and Cys210 which is conserved across all opioid receptors. <scene name='48/483884/K_or_ligand_biding_pocket_asp/1'>Active site</scene> of κ-opioid receptor. The human κ-opioid receptor ligand binding pocket displays a unique combination of key characteristics both shared with and distinct from those in the chemokine and aminergic receptor families.
The κ-opioid receptor is a <scene name='48/483884/K_or_general/1'>homodimer</scene>. The extracellular side is home to the proteins primary <scene name='48/483884/K_or_binding_general/2'>active site</scene>. These 2 units will span the length for the cell membrane to form the basis of the receptor molecule. <scene name='48/483884/K_or_dimmer_assembly/1'>The each subunit is attached to the other by the I, II and VIII α-helices</scene>, where helices I (in light blue) and helices VIII (in dark blue). This area will make up the basis for the intermembrane surface area. A distinguishing feature that separates the κ-opioid receptor from other receptors, is the large β-hairpin, <scene name='48/483884/K_or_beta_sheet/3'>ECL2</scene>, located near the main active site of the protein. It is believed that its function is to cap the active site of the receptor. Although in general, this protein is primarily composed of α-helices, not β-sheets (Compare <scene name='48/483884/K_or_beta_sheet/1'>β-sheet</scene> to <scene name='48/483884/K_or_alpha/1'>α-helices</scene>). This evidence reinforces the idea that this protein is a transmembrane protein rather than one found inside the cytosol. In general transmembrane protein are composed almost entirely of α-helices (or β-sheet arranged in special fashion called a β-barrel), in order to have maximum stability inside the membrane. Interesting feature of the κ-opioid receptor is the <scene name='48/483884/K_or_disulfide_bond/1'>disulfide bond </scene> formed by Cys131 and Cys210 which is conserved across all opioid receptors. <scene name='48/483884/K_or_ligand_biding_pocket_asp/1'>Active site</scene> of κ-opioid receptor. The human κ-opioid receptor ligand binding pocket displays a unique combination of key characteristics both shared with and distinct from those in the chemokine and aminergic receptor families.
* The '''δ-opioid receptor''' binds enkephalins. For details see [[Delta opioid receptor]].
* The '''δ-opioid receptor''' binds enkephalins. For details see [[Delta opioid receptor]].
 +
Opioid receptors typically have 2 big portions: the upper portion, zoomed in here with <scene name='71/715422/Sceneactivesite/1'>active site</scene> shown in indigo, that is ligand specific and recognizes a particular ligand, and the lower portion which is highly conserved amongst all receptors. When <scene name='71/715422/Sceneligand/1'>Naltrindole</scene> approaches δ-opioid receptor, it is distinguished by the high hydrophobic interaction between the indole group on the ligand and leucine 300 on the receptor. As it glides deeper into the binding site facilitated by the hydrophobic interaction, the hydroxyl group of the tyrosine-like phenol group hydrogen bonds with water molecules which are hydrogen bound to a critical histidine 248. This holds the ligand by having both the phenol group and histidine anchored by a water molecule. The water molecules within the binding pocket flank both the ligand and receptor, serving almost as a scaffolding on which for both components to act. Adjacent to the phenol group, the oxygen of an ether is hydrogen bound to tyrosine 129 of the receptor. On the opposite side of the binding site, Asp128 forms a salt bridge with the charged amino group on the ligand. The rest of the ligand maintains hydrophobic contact with non-polar residues of the binding site. The phenol to water interaction is a conserved interaction between many opioid receptors and their respective ligands as evidenced by many natural antagonists having a tyrosine that interacts with a water molecule in a similar fashion.
* The '''Nociceptin/orphanin FQ opioid receptor''' binds the heptadecapeptide orphanin<ref>PMID:23395957</ref>.
* The '''Nociceptin/orphanin FQ opioid receptor''' binds the heptadecapeptide orphanin<ref>PMID:23395957</ref>.

Revision as of 12:50, 24 May 2021

Structure of κ-opioid receptor complex with opioid antagonist, citric acid, PEG and octadec-enoate derivative (PDB entry 4djh)

Drag the structure with the mouse to rotate

References

  1. Feng Y, He X, Yang Y, Chao D, Lazarus LH, Xia Y. Current research on opioid receptor function. Curr Drug Targets. 2012 Feb;13(2):230-46. PMID:22204322
  2. Donica CL, Awwad HO, Thakker DR, Standifer KM. Cellular mechanisms of nociceptin/orphanin FQ (N/OFQ) peptide (NOP) receptor regulation and heterologous regulation by N/OFQ. Mol Pharmacol. 2013 May;83(5):907-18. doi: 10.1124/mol.112.084632. Epub 2013 Feb , 8. PMID:23395957 doi:http://dx.doi.org/10.1124/mol.112.084632

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Michal Harel

Personal tools